Abbott Laboratories (ABT)

Sector: Healthcare
Industry: Pharmaceutical Preparations
Country: United States
Exchange: NYSE
Market cap: $179.90B
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.
Latest financial period: September 30, 2026
Filed with the SEC: November 4, 2026
Estimated earnings date: Not available
Profit #763 of 1422 companies
| | Sep 26 | Jun 26 | Mar 26 | Dec 25 |
|---|
| ROIC | 9.7% | 10.0% | 10.5% | 12.0% |
Growth #851 of 1422 companies
Payout #124 of 1422 companies
Safety #139 of 1422 companies
Price #986 of 1422 companies